Market Overview:
The global picrotoxin market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for picrotoxin as an anticonvulsant drug and its growing use in research and development activities. Picrotoxin is also used as a tool for studying GABAergic transmission and has various applications such as GABA antagonist, extracellular saline, artificial cerebrospinal fluid, and others. North America dominates the global picrotoxin market followed by Europe, Asia Pacific, Latin America, and Middle East & Africa respectively.
Product Definition:
Picrotoxin is a poison that blocks the action of GABA, an inhibitory neurotransmitter. Picrotoxin is used to study the function of GABA in the brain.
≥ 97.0%:
Picrotoxin is a highly potent and selective inhibitor of voltage-gated sodium channels. It has been reported that the concentration of picrotoxin needed to inhibit 50% of the current through a patch pipette is less than 1mM.
< 97.0%:
Picrotoxin is a 97% pure and highly concentrated form of the active ingredient. It is used as an insecticide for crops such as cotton, corn, soybean, wheat, and rice. Picrotoxin also finds application in forestry to control insects like scales on trees and other plants.
Application Insights:
The other application segment includes picrotoxin for injection into the cerebrospinal fluid to treat meningitis and encephalitis. The product is also used in extracellular saline solutions, which are used as a substitute for normal blood plasma and its components. Increasing cases of central nervous system disorders across the globe are expected to boost demand for these products over the forecast period.
Growth in demand from various applications including artificial cerebrospinal fluid and intrathecal pumps is anticipated to drive growth over the forecast period. In addition, increasing awareness about neurological diseases coupled with rising healthcare spending in emerging economies such as India, China and Brazil is expected to propel industry expansion over the next eight years.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to increasing product consumption for treatment of epilepsy and status epilepticus. In addition, rising prevalence of neurodegenerative diseases such as Parkinson’s disease, Alzheimer's disease, and Huntington’s disease is also anticipated to drive regional growth over the forecast period.
Asia Pacific market was valued at USD X million in 2017 and is expected to witness lucrative growth over the projected period due to growing awareness about neurological disorders among people especially students & young professionals along with rising healthcare expenditure by government & private sectors in countries like India & China which are major markets for picrotoxin like Japan, Australia etc.). Moreover, increasing R&D activities by various companies will fuel regional demand during the estimated time span from 2018-2030 (estimated CAGR of XX% from 2018 To 2030).
Growth Factors:
- Increasing demand for picrotoxin in the pharmaceutical and biotechnology industries for research and development purposes.
- Rising demand from emerging markets due to increasing awareness about its benefits.
- Growing use of picrotoxin as a flavoring agent in food and beverage products.
- Increasing application of picrotoxin in animal husbandry and veterinary medicine sectors to treat livestock diseases.
Scope Of The Report
Report Attributes
Report Details
Report Title
Picrotoxin Market Research Report
By Type
≥ 97.0%, < 97.0%
By Application
GABA Antagonist, Extracellular Saline, Artificial Cerebrospinal Fluid, Other
By Companies
Merck, Biosynth, Cayman Chemical, Alomone Labs, Merck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
133
Number of Tables & Figures
94
Customization Available
Yes, the report can be customized as per your need.
Global Picrotoxin Market Report Segments:
The global Picrotoxin market is segmented on the basis of:
Types
≥ 97.0%, < 97.0%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
GABA Antagonist, Extracellular Saline, Artificial Cerebrospinal Fluid, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Biosynth
- Cayman Chemical
- Alomone Labs
- Merck
Highlights of The Picrotoxin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ≥ 97.0%
- < 97.0%
- By Application:
- GABA Antagonist
- Extracellular Saline
- Artificial Cerebrospinal Fluid
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Picrotoxin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Picrotoxin is a neurotoxin that is found in the venom of some snakes. It can cause paralysis and death in humans.
Some of the major players in the picrotoxin market are Merck, Biosynth, Cayman Chemical, Alomone Labs, Merck.
The picrotoxin market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Picrotoxin Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Picrotoxin Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Picrotoxin Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Picrotoxin Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Picrotoxin Market Size & Forecast, 2020-2028 4.5.1 Picrotoxin Market Size and Y-o-Y Growth 4.5.2 Picrotoxin Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 ≥ 97.0%
5.2.2 < 97.0%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 GABA Antagonist
6.2.2 Extracellular Saline
6.2.3 Artificial Cerebrospinal Fluid
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Picrotoxin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Picrotoxin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 ≥ 97.0%
9.6.2 < 97.0%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 GABA Antagonist
9.10.2 Extracellular Saline
9.10.3 Artificial Cerebrospinal Fluid
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 ≥ 97.0%
10.6.2 < 97.0%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 GABA Antagonist
10.10.2 Extracellular Saline
10.10.3 Artificial Cerebrospinal Fluid
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 ≥ 97.0%
11.6.2 < 97.0%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 GABA Antagonist
11.10.2 Extracellular Saline
11.10.3 Artificial Cerebrospinal Fluid
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 ≥ 97.0%
12.6.2 < 97.0%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 GABA Antagonist
12.10.2 Extracellular Saline
12.10.3 Artificial Cerebrospinal Fluid
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 ≥ 97.0%
13.6.2 < 97.0%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 GABA Antagonist
13.10.2 Extracellular Saline
13.10.3 Artificial Cerebrospinal Fluid
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Picrotoxin Market: Competitive Dashboard
14.2 Global Picrotoxin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Biosynth
14.3.3 Cayman Chemical
14.3.4 Alomone Labs
14.3.5 Merck